Joaquín Osca, MD, PhD is an expert in Cardiology at Hospital Universitari i Politècnic La Fe (Spain). As of October 2026, ScienceLeadR ranks Joaquín Osca in the top 1% of experts in Spain for Pulsed Field Ablation. Joaquín Osca has authored 197 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 3 of them ongoing. SLR score: 620 (community average: 125). How the SLR is computed.

LeadR Profile

Joaquín Osca, MD, PhD Hospital Universitari i Politècnic La Fe Spain
620 ScienceLeadR Reputation 620
Network Map

Cardiology

Subspecialties: Public Health - Biochemistry - Preventive Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Hospital Universitari i Politècnic La Fe

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 197

Citations

Citations: 3 099 1st author: 37 Last author: 15 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Conduction Guided Intervention: A First-in-Human Study of CTA-Guided Targeting of Proximal Conduction System Structures.
PMID 42409231 — arrhythmias, cardiac
Heart Rhythm20262
Safety and Effectiveness of the TactiFlex Duo System: 6-Month Results of the FOCALFLEX Study.
PMID 42097576 — safety, atrial fibrillation, radiofrequency ablation
Europace20260
Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation.
PMID 42041224 — safety, pharmaceutical preparations, arrhythmias, cardiac, drug therapy, atrial fibrillation, drug-related side effects and adverse reactions, anti-arrhythmia agents, therapeutics, catheters, pulsed field ablation
N Engl J Med Top journal20260
Adjunctive Posterior Wall Ablation with a Balloon-in-Basket Pulsed-Field Ablation Catheter in Atrial Fibrillation: Feasibility, Safety, and Insights into Targeted Lesion Delivery from the VOLT CE Mark Study.
PMID 42028834 — safety, atrial fibrillation, catheter ablation, catheters, pulsed field ablation
Europace20260
Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry.
PMID 41914181 — registries, embolism, stroke, incidence, atrial fibrillation, cardiology, lasers, pulsed field ablation
Eur Heart J Top journal20261

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 11
Phase 3 1
Phase 4 1

By status:

Completed 9
Active not recruiting 2
Recruiting 1
Terminated 1

By type:

Interventional 11
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 2
multicentricup10 9

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
BaLloon based PFA Ablation poST Approval Outcomes for PAF and PersAF
NCT07181590 — arrhythmias, cardiac, atrial fibrillation, pulsed field ablation
N/ARecruiting2025
Pulsed Field Ablation (PFA) vs Anti Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
NCT06096337 — pulmonary veins, heart diseases, pharmaceutical preparations, propafenone, heart, cardiovascular diseases, sotalol, atrial fibrillation, anti-arrhythmia agents, drug delivery systems, therapeutics, flecainide, veins, dronedarone, pulsed field ablation
N/AActive not recruiting2023
Stroke Prevention and Rhythm Control Therapy STEEER AF
NCT04396418 — guideline adherence, stroke, atrial fibrillation, cardiology, therapeutics, education, random allocation
N/AActive not recruiting2021

LeadR Networks

Main global connection map